Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
He moved to Singapore in 2000 to manage IFRs financial markets editorial team throughout Asia, before returning to London in 2009 to take up the position of Publisher for Reuters Capital Markets Publications
Yeah, I'm excited to be here
Kahn MA, Weathers DR, Hoffman JG
Effects of evolocumab combined with L-carnitine on prognosis of research subjects [PMID: 41796518] Laboratory literature summary: Effects of evolocumab combined with L-carnitine on prognosis of research subjects after emergency PCI
US$ 21.84
US$ 23.20
US$ 21.22
US$ 27.62
US$ 28.75
